Evidence map›Paper›PMID 27619989›Full record

ArticleFamilial cancer2017

Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.

Walid Sabri Hamadou, Sawsen Besbes, Violaine Bourdon, Yosra Ben Youssef, Mohamed Adnène Laatiri, Testsuro Noguchi, Abderrahim Khélif, Hagay Sobol, Zohra Soua

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Walid Sabri HamadouRU "Molecular Biology of Leukemias and Lymphomas", Laboratory of Biochemistry, Faculty of Medicine of Sousse, University of Sousse, Avenue Mohamed Karoui, 4000, Sousse, Tunisia. walid_sabrimail@yahoo.fr.
Sawsen BesbesRU "Molecular Biology of Leukemias and Lymphomas", Laboratory of Biochemistry, Faculty of Medicine of Sousse, University of Sousse, Avenue Mohamed Karoui, 4000, Sousse, Tunisia.
Violaine BourdonDepartment of Genetic Oncology, Prevention and Screening, Institute Paoli-Calmettes, Marseille, France.
Yosra Ben YoussefService of Clinical Hematology, CHU Farhat Hached, Sousse, Tunisia.
Mohamed Adnène LaatiriService of Clinical Hematology, CHU Fattouma Bourguiba, Monastir, Monastir, Tunisia.
Testsuro NoguchiDepartment of Genetic Oncology, Prevention and Screening, Institute Paoli-Calmettes, Marseille, France.
Abderrahim KhélifService of Clinical Hematology, CHU Farhat Hached, Sousse, Tunisia.
Hagay SobolDepartment of Genetic Oncology, Prevention and Screening, Institute Paoli-Calmettes, Marseille, France.
Zohra SouaRU "Molecular Biology of Leukemias and Lymphomas", Laboratory of Biochemistry, Faculty of Medicine of Sousse, University of Sousse, Avenue Mohamed Karoui, 4000, Sousse, Tunisia.
Institut Paoli-Calmettes · FRUniversity of Sousse · TNHôpital Farhat Hached · TNHospital Fatuma Bourguiba Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations are responsible for familial cancer syndromes which account for approximately 5-10 % of all types of cancers. Familial cancers are often caused by genetic alterations occurring either in tumor suppressor or genomic stability genes such as TP53. In this study, we have analyzed the TP53 gene by direct sequencing approach, in a panel of 18 Tunisian familial hematological malignancies cases including several forms of leukemia, lymphoma and myeloid syndrome and 22 cases of sporadic acute leukemia. In one familial case diagnosed with acute lymphoblastic leukemia, we reported an intronic substitution 559+1 G>A which may disrupt the splice site and impact the normal protein function. Most of the deleterious mutations (Arg158His; Pro282Trp; Thr312Ser) as classified by IARC data base, were commonly reported in ALL cases studied here. The cosegregation of the two variants rs1042522 and rs1642785 was observed in most patients which may be in favor of the presence of linkage disequilibrium. The most defined TP53 mutations found here were identified in acute lymphoblastic leukemia context whereas only 3 % of mutations have been in previous studies. The cosegregation of the two recurrent variant rs1042522 and rs1642785 should be further confirmed.

Indexed as

MutationDNA Mutational AnalysisHematologic NeoplasmsHumansLeukemiaPedigreePrecursor Cell Lymphoblastic Leukemia-LymphomaTumor Suppressor Protein p53TunisiaTP53 protein, humanTumor Suppressor Protein p53Acute lymphoblastic leukemiaAcute myeloid leukemiaFamilial hematological malignanciesTP53 gene mutations

Identifiers

PMID27619989
OpenAlexW2519301911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.